Recent Quotes
View Full List
My Watchlist
American Lithium Corp
American Lithium Corp. - Common Stock
AppTech Payments Corp. - Common stock
Calibre Mining Corp
Canalaska Uranium Ltd
Canter Resources Corp
Denison Mines Corp.
E3 Lithium Ltd
F3 Uranium Corp
Filo Corp
Filo Mining Corp
Fission Uranium
Fission Uranium
Grounded Lithium Corp
Isoenergy Ltd
Lithium South Dev Corp
Lundin Mining Corporation
Pressure Biosciences Inc
Rocket Doctor Ai Inc
Silver
Surge Battery Metals Inc
Telo Genomics Corp
Treatment.com Ai Inc
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Cyllene Therapeutics
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Conference
October 07, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer
September 17, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)
September 14, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
July 23, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Tickers
NKTX
Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
July 07, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.